Walmart to replace Astrazeneca on Nasdaq-100 on Jan 20
Tweet
Share
E-mail
A Walmart worker in a holiday costume gathers shopping carts in the parking area of a Walmart Supercenter store in Monroe, New York, U.S., December 9, 2025. REUTERS/Mike Segar
Jan 9 (Reuters) - Walmart will replace British drugmaker AstraZeneca in the Nasdaq-100 Index on January 20, the exchange operator said on Friday.
The retail giant said in November it would shift its longtime listing on the New York Stock Exchange to its main rival.
Companies typically change listing venues when they see better alignment with an exchange's investor base, technology and services, or when they want to cut costs tied to listing and compliance.
Some companies that transferred from NYSE to Nasdaq in 2025 cited as a key reason the attractiveness of the Nasdaq-100 index - which includes 100 of the most valuable non-financial companies listed on the Nasdaq, including Nvidia and Apple.
Walmart will replace AstraZeneca in the Nasdaq-100 Index, the Nasdaq-100 Equal Weighted Index, and the Nasdaq-100 Ex-Tech Sector Index, before market open on January 20, Nasdaq said in a statement.
(Reporting by Rhea Rose Abraham in Bengaluru; Editing by Tom Hogue)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Iran warns US, Israel against attacks ahead of funeral processions for Khamenei
- European shares rise as defensives counter tech slide
- Japan's yen jumps, with traders twitchy about intervention risk
Create E-mail Alert Related Categories
ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
